Browse the evidence

Biomechanical variations of the push-up can impact muscle recruitment patterns and joint stresses.

Trainers should customize push-up variations to meet individual client needs.

Whole egg intake may enhance muscle mass independent of its protein content.

Incorporating whole eggs into the diet may support muscle mass gains.

The intake of whole egg promotes greater myofibrillar protein synthesis than egg white intake in young men.

Whole eggs may be more effective than egg whites for promoting muscle protein synthesis.

Women on hormone therapy (HT) had a higher total body weight loss percentage (TBWL%) at 3, 6, 9, and 12 months compared to women not on HT.

Practitioners may consider hormone therapy as a factor in weight loss strategies for postmenopausal women.

A greater percentage of women on HT achieved ≥5% and ≥10% total body weight loss at 12 months.

This suggests that hormone therapy may enhance the effectiveness of weight loss treatments.

Both resistance training groups (multijoint to single-joint and single-joint to multijoint) showed significant increases in muscle strength (16.4% and 12.7%, respectively) after 12 weeks.

Both training orders are effective for improving muscle strength in older women.

Both resistance training groups experienced significant increases in muscle mass (7.5% for MJ-SJ and 6.1% for SJ-MJ) after 12 weeks.

Both training orders are effective for increasing muscle mass in older women.

Exercise is a key component of nonalcoholic fatty liver disease (NAFLD) treatment.

Practitioners should incorporate exercise into treatment plans for NAFLD.

Exercise training modulates fatty acid metabolism, reduces hepatic inflammation, and improves liver fibrosis.

Exercise should be tailored to target these specific metabolic and inflammatory pathways.

The effectiveness of exercise in improving NAFLD is influenced by exercise type, intensity, and volume.

Exercise programs should consider these factors to optimize treatment outcomes.

ω-3-PL/FFA reduced triglyceride (TG) levels by 26.0% at 12 weeks compared to 15.1% in the placebo group.

Practitioners can consider ω-3-PL/FFA as an effective option for lowering TG levels in patients with severe hypertriglyceridemia.

Hip extension exercises might transfer better to sport actions where the region of force accentuation is most specific.

Practitioners should consider the specificity of hip extension exercises when designing training programs.

Regular physical activity participation can aid in preventing chronic diseases.

Encouraging regular physical activity is essential for chronic disease prevention.

Tirzepatide administration for 72 weeks elicited significant weight reduction ranging from 5% to 20.9% across different trials in a dose-dependent manner.

Tirzepatide may be an effective option for weight management in patients with obesity and T2DM.

Tirzepatide significantly decreased food intake and reduced overall appetite scores.

Tirzepatide may help reduce appetite, aiding in weight loss efforts.

Tirzepatide exhibited favorable effects on glycemic control, with reductions in HbA1c levels ranging from 20.4 mmol/mol with the 5 mg dose to 28.2 mmol/mol with the 15 mg dose.

Tirzepatide may improve glycemic control in patients with T2DM.

GLP-1 receptor agonists (GLP-1RAs) are effective for reducing body weight and are approved for the treatment of obesity.

GLP-1RAs can be considered as a treatment option for patients struggling with obesity.

Liraglutide is approved for the treatment of obesity.

Liraglutide can be prescribed for obesity management.

Tirzepatide resulted in mean waist circumference reductions ranging from 4.3 to 9.8 cm across subgroups.

Tirzepatide is effective in reducing waist circumference in East Asian individuals with type 2 diabetes.

Both American and European guidelines encourage heart-healthy diets consistent with Mediterranean, DASH, or healthy vegetarian patterns.

Clinicians should recommend these dietary patterns for CVD prevention.

Increased loading as resistance training is the most potent nonpharmacological strategy by which skeletal muscle mass can be increased.

Practitioners should prioritize resistance training to enhance muscle mass.

Recently developed therapeutics may enable effective management of body weight in patients with obesity.

Healthcare providers may consider new therapeutics for obesity management.

Lean mass increased after resistance exercise training (RET) by +3.2% ± 1.6% and after high-intensity interval training (HIIT) by +1.6% ± 2.1% (P < 0.05).

Incorporating RET and HIIT can effectively increase lean mass in middle-aged men.

Muscle strength increased after all training interventions: RET by +25% ± 5%, HIIT by +10% ± 5%, and endurance training (ENT) by +7% ± 7% (P < 0.05).

All forms of exercise training can enhance muscle strength in middle-aged men.